Cargando…

Threat-Modulation of Executive Functions—A Novel Biomarker of Depression?

Background: Alterations in executive functions, emotion regulation, and their interaction are common concomitants of depression. Executive dysfunction frequently lingers after treatment, has adverse effects on daily life, and predisposes to recurrence of depression. Yet, sensitive measures of execut...

Descripción completa

Detalles Bibliográficos
Autores principales: Peräkylä, Jari, Järventausta, Kaija, Haapaniemi, Piia, Camprodon, Joan A., Hartikainen, Kaisa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283506/
https://www.ncbi.nlm.nih.gov/pubmed/34276442
http://dx.doi.org/10.3389/fpsyt.2021.670974
_version_ 1783723218533613568
author Peräkylä, Jari
Järventausta, Kaija
Haapaniemi, Piia
Camprodon, Joan A.
Hartikainen, Kaisa M.
author_facet Peräkylä, Jari
Järventausta, Kaija
Haapaniemi, Piia
Camprodon, Joan A.
Hartikainen, Kaisa M.
author_sort Peräkylä, Jari
collection PubMed
description Background: Alterations in executive functions, emotion regulation, and their interaction are common concomitants of depression. Executive dysfunction frequently lingers after treatment, has adverse effects on daily life, and predisposes to recurrence of depression. Yet, sensitive measures of executive function for reliable assessment of cognitive outcomes are still lacking in clinical practice. To better understand the impact of depression and its most effective treatment, electroconvulsive therapy (ECT), on cognition, we assessed executive functions pre- and post-ECT and whether objective measures reflecting alterations in emotion–executive function interaction correlate with depression severity or with cognitive outcome. Methods: Executive functions were assessed in 21 patients with major depressive disorder (MDD) before and after ECT using subjective measures from the Behavior Rating Inventory of Executive Function—Adult version (BRIEF-A) and objective cognitive performance measures derived from computer-based test of executive function, Executive Reaction Time (RT) Test. In addition, we created novel indices reflecting emotional modulation of cognitive performance by subtracting different performance measures in the context of neutral distractors from those in the context of threat-related distractors. We correlated these indices with Beck Depression Inventory (BDI) and BRIEF-A scores. Results: Depression was significantly alleviated, and executive functions improved post-ECT, as seen in reduced BDI scores, BRIEF-A scores, and number of errors in Executive RT Test. Pre-ECT BDI scores correlated with threat modulation of RT (tmRT) and threat modulation of working memory (tmWM). Post-ECT tmRT correlated with several Behavioral Regulation scales and tmWM with several Metacognition scales of BRIEF-A. Conclusion: While caution is warranted, results from both subjective and objective measures suggest that ECT significantly improves executive functions and emotion regulation along with alleviation of depression. Novel indices derived from threat modulation of executive function and working memory show promise as objective biomarkers of depression severity pre-ECT and cognitive outcome post-ECT with potential for guiding depression treatments.
format Online
Article
Text
id pubmed-8283506
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82835062021-07-17 Threat-Modulation of Executive Functions—A Novel Biomarker of Depression? Peräkylä, Jari Järventausta, Kaija Haapaniemi, Piia Camprodon, Joan A. Hartikainen, Kaisa M. Front Psychiatry Psychiatry Background: Alterations in executive functions, emotion regulation, and their interaction are common concomitants of depression. Executive dysfunction frequently lingers after treatment, has adverse effects on daily life, and predisposes to recurrence of depression. Yet, sensitive measures of executive function for reliable assessment of cognitive outcomes are still lacking in clinical practice. To better understand the impact of depression and its most effective treatment, electroconvulsive therapy (ECT), on cognition, we assessed executive functions pre- and post-ECT and whether objective measures reflecting alterations in emotion–executive function interaction correlate with depression severity or with cognitive outcome. Methods: Executive functions were assessed in 21 patients with major depressive disorder (MDD) before and after ECT using subjective measures from the Behavior Rating Inventory of Executive Function—Adult version (BRIEF-A) and objective cognitive performance measures derived from computer-based test of executive function, Executive Reaction Time (RT) Test. In addition, we created novel indices reflecting emotional modulation of cognitive performance by subtracting different performance measures in the context of neutral distractors from those in the context of threat-related distractors. We correlated these indices with Beck Depression Inventory (BDI) and BRIEF-A scores. Results: Depression was significantly alleviated, and executive functions improved post-ECT, as seen in reduced BDI scores, BRIEF-A scores, and number of errors in Executive RT Test. Pre-ECT BDI scores correlated with threat modulation of RT (tmRT) and threat modulation of working memory (tmWM). Post-ECT tmRT correlated with several Behavioral Regulation scales and tmWM with several Metacognition scales of BRIEF-A. Conclusion: While caution is warranted, results from both subjective and objective measures suggest that ECT significantly improves executive functions and emotion regulation along with alleviation of depression. Novel indices derived from threat modulation of executive function and working memory show promise as objective biomarkers of depression severity pre-ECT and cognitive outcome post-ECT with potential for guiding depression treatments. Frontiers Media S.A. 2021-07-02 /pmc/articles/PMC8283506/ /pubmed/34276442 http://dx.doi.org/10.3389/fpsyt.2021.670974 Text en Copyright © 2021 Peräkylä, Järventausta, Haapaniemi, Camprodon and Hartikainen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Peräkylä, Jari
Järventausta, Kaija
Haapaniemi, Piia
Camprodon, Joan A.
Hartikainen, Kaisa M.
Threat-Modulation of Executive Functions—A Novel Biomarker of Depression?
title Threat-Modulation of Executive Functions—A Novel Biomarker of Depression?
title_full Threat-Modulation of Executive Functions—A Novel Biomarker of Depression?
title_fullStr Threat-Modulation of Executive Functions—A Novel Biomarker of Depression?
title_full_unstemmed Threat-Modulation of Executive Functions—A Novel Biomarker of Depression?
title_short Threat-Modulation of Executive Functions—A Novel Biomarker of Depression?
title_sort threat-modulation of executive functions—a novel biomarker of depression?
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283506/
https://www.ncbi.nlm.nih.gov/pubmed/34276442
http://dx.doi.org/10.3389/fpsyt.2021.670974
work_keys_str_mv AT perakylajari threatmodulationofexecutivefunctionsanovelbiomarkerofdepression
AT jarventaustakaija threatmodulationofexecutivefunctionsanovelbiomarkerofdepression
AT haapaniemipiia threatmodulationofexecutivefunctionsanovelbiomarkerofdepression
AT camprodonjoana threatmodulationofexecutivefunctionsanovelbiomarkerofdepression
AT hartikainenkaisam threatmodulationofexecutivefunctionsanovelbiomarkerofdepression